Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-16), National Healthcare's 12-1 Month Momentum % is N/A%.
The industry rank for National Healthcare's 12-1 Month Momentum % or its related term are showing as below:
FRA:HTW's 12-1 Month Momentum % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -13.54 * Ranked among companies with meaningful 12-1 Month Momentum % only.
National Healthcare (FRA:HTW) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
National Healthcare 12-1 Month Momentum % Related Terms
National Healthcare (FRA:HTW) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare (FRA:HTW) has a 12-1 Month Momentum % of N/A% as of Aug. 16, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on National Healthcare and its competitors. According to the industry distribution chart, National Healthcare ranks #33 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 5%.
Is National Healthcare's 12-1 Month Momentum % too high?
National Healthcare's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, National Healthcare ranks #33 out of 661 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's 12-1 Month Momentum % compare to BKD and OPCH?
According to the Healthcare Providers & Services industry distribution chart, National Healthcare ranks #33 out of 661 companies for 12-1 Month Momentum %. This places National Healthcare in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on National Healthcare and its competitors. National Healthcare's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current 12-1 Month Momentum % of N/A%. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current 12-1 Month Momentum % is N/A%. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current 12-1 Month Momentum % is N/A% as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
12-1 Month Momentum %: N/A%
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
